Open Access
AJP Rep 2013; 03(01): 025-028
DOI: 10.1055/s-0032-1329683
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Utility of Maternal 6-Thioguanine Nucleotide Levels in Predicting Neonatal Pancytopenia

Autoren

  • Hidehiko Maruyama

    1   Department of Neonatology, National Hospital Organization, Okayama Medical Center, Okayama, Japan
  • Katsuhiko Tada

    2   Department of Obstetrics and Gynecology, National Hospital Organization, Okayama Medical Center, Okayama, Japan
  • Takuzo Fujiwara

    3   Department of Surgery, National Hospital Organization, Okayama Medical Center, Okayama, Japan
  • Kosuke Ota

    4   Department of Nephrology, National Hospital Organization, Okayama Medical Center, Okayama, Japan
  • Misao Kageyama

    1   Department of Neonatology, National Hospital Organization, Okayama Medical Center, Okayama, Japan
Weitere Informationen

Publikationsverlauf

24. Mai 2012

27. Juli 2012

Publikationsdatum:
03. Dezember 2012 (online)

Abstract

An infant with pancytopenia was born to a mother who used the common immunosuppressant azathioprine (AZA). Maternal and neonatal blood levels of 6-thioguanine nucleotides (6TGN; metabolite of AZA) were 1890 and 1480 pmol/8 × 108 red blood cells, respectively. Maternal 6TGN levels could be useful in predicting neonatal pancytopenia.